Medartis Holding AG, a leading original equipment manufacturer (OEM) specialized in medical devices for internal surgical bone fixation, completed its initial public offering (IPO) on the SIX Swiss Exchange on 23 March 2018. Based on an opening price of CHF 54.00 the market capitalization of Medartis is CHF 633 Mio. Founded in 1997 by Dr. h.c. Thomas Straumann, Medartis has emerged as a company recognized by medical professionals for its innovation in designing and manufacturing fixation system solutions, enabling them to treat small-bone fractures and osteotomies in the lower and upper extremities, as well as of the craniomaxil-lofacial (CMF) region, for the benefit of their patients. Underwriters for the IPO were Zürcher Kantonalbank, Bryan, Garnier & Co and Kepler Cheuvreux.
VISCHER AG is acting as legal counsel to the issuer with Matthias Staehelin (Partner, Corporate) as team leader, Stefan Grieder (Partner, Corporate), Angelo Imperiale (Associate, Corporate), Nadia Tarolli (Partner, Tax), Adrian Briner (Associate, Tax) and Sebastian Wyler (Trainee, Corporate).